![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Oklahoma Judge Rules Against Teva J&J in Opioid Suit
Oklahoma Judge Rules Against Teva J&J in Opioid Suit
![GavelwithSilveronIt.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/GavelwithSilveronIt.gif?t=1576046135&width=430)
May 22, 2019
An Oklahoma judge has ruled against Teva and Johnson & Johnson in their efforts to have the state’s opioid lawsuit tossed.
Cleveland County District Court Judge Thad Balkman said neither of the drug giants had met their burden to have the case tossed on summary judgment. The case is now headed for trial in about one week—the first of 37 such cases across the country.
Oklahoma Attorney General Mike Hunter is claiming that the drug companies’ opioid business constitutes a public nuisance and is demanding millions in damages.
Upcoming Events
-
21Oct